• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2012 Fiscal Year Final Research Report

Akt kinase-interacting protein1, a novel therapeutic target for lung cancer with EGFR-activating and gatekeeper mutations

Research Project

  • PDF
Project/Area Number 23790902
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Respiratory organ internal medicine
Research InstitutionKanazawa University

Principal Investigator

YAMADA Tadaaki  金沢大学, 大学病院, 講師 (00507048)

Project Period (FY) 2011 – 2012
Keywords肺癌 / 分子標的治療 / EGFR変異
Research Abstract

We focused on Akt kinase-interacting protein1 (Aki1), a scaffold protein of PI3K /PDK1/Akt, and assessed its role in EGFR mutant lung cancer. Aki1 constitutively associates with mutant EGFR in lung cancer cells. Silencing of Aki1 inhibited cell growth of EGFR mutant lung cancer cells and induced apoptosis of them. Treatment with Aki1 siRNA dramatically inhibited growth of EGFR mutant lung cancer cells in a xenograft model. Moreover, Aki1 was frequently expressed in tumor cells of EGFR mutant lung cancer patients, including those with acquired resistance to EGFR-TKI treatment. Our data suggest that Aki1 may be an ideal target for EGFR mutant lung cancer patients, especially those with acquired EGFR-TKI resistance due to EGFR T790M gatekeeper mutation.

  • Research Products

    (16 results)

All 2013 2012 2011 Other

All Journal Article (6 results) (of which Peer Reviewed: 6 results) Presentation (7 results) Book (2 results) Remarks (1 results)

  • [Journal Article] Akt kinase-interacting protein1, a novel therapeutic target for lung cancer with EGFR activating and gatekeeper mutations.2012

    • Author(s)
      Yamada T, Takeuchi S, Fujita N, Nakamura A, Wang W, Li Q, Oda M, Mitsudomi T, Yatabe Y, Sekido Y, Yoshida J, Higashiyama M, Noguchi M, Uehara H, Nishioka Y, Sone S, Yano S.
    • Journal Title

      Oncogene

      Volume: (in press)

    • DOI

      DOI:10.1038/onc.2012.446

    • Peer Reviewed
  • [Journal Article] Paracrine receptor activation by microenvironment triggers bypass survival signals and ALK inhibitor resistance in EML4-ALK lung cancer cells.2012

    • Author(s)
      Yamada T, Takeuchi S, Nakade J, Kita K, Nakagawa T, Nanjo S, Soda M, Mano H, Uenaka T, Yano S.
    • Journal Title

      Clin Cancer Res

      Volume: 18 Pages: 3592-3602

    • DOI

      DOI:10.1158/1078-0432.CCR-11-2972

    • Peer Reviewed
  • [Journal Article] Hsp90 inhibition overcomes HGF-triggering resistance to EGFR-TKIs in EGFR mutant lung cancer by decreasing client protein expression and angiogenesis.2012

    • Author(s)
      Koizumi H, Yamada T, Takeuchi S, Nakagawa T, Kita K, Nakamura T, Matsumoto K, Yano S.
    • Journal Title

      J Thorac Oncol

      Volume: 7 Pages: 1078-1085

    • DOI

      DOI:10.1097/JTO.0b013e3182519a2c

    • Peer Reviewed
  • [Journal Article] Hepatocyte Growth Factor Induces Resistance to Anti-Epidermal Growth Factor Receptor Antibody in Lung Cancer.2012

    • Author(s)
      Yamada T, Takeuchi S, Kita K, Bando H, Nakamura T, Matsumoto K, Yano S.
    • Journal Title

      J Thorac Oncol

      Volume: 7 Pages: 272-280

    • DOI

      DOI:10.1097/JTO.0b013e3182398e69

    • Peer Reviewed
  • [Journal Article] Genetically engineered humanized anti-ganglioside GM2 antibody against multiple organ metastasis produced by GM2-expressing small cell lung cancer cells.2011

    • Author(s)
      Yamada T, Bando H, Takeuchi S, Kita K, Li Q, Wang W, Akinaga S, Nishioka Y, Sone S, Yano S.
    • Journal Title

      Cancer Sci

      Volume: 102 Pages: 2157-2163

    • DOI

      DOI:10.1111/j.1349-7006.2011.02093.x

    • Peer Reviewed
  • [Journal Article] EGFR ligands, Amphiregulin and Heparin-binding EGF-like Growth Factor Promote Peritoneal Carcinomatosis in CXCR4-expressing Gastric Cancer.2011

    • Author(s)
      Yasumoto K, Yamada T, Kawashima A, Wang W , Li Q, Donev IS, Tacheuchi S, Mouri H, Yamashita K, Ohtsubo K, Yano S.
    • Journal Title

      Clin Cancer Res

      Volume: 17 Pages: 3619-3630

    • DOI

      DOI:10.1158/1078-0432.CCR-10-2475

    • Peer Reviewed
  • [Presentation] Paracrine receptor ligands activate bypass tracts and cause ALK inhibitor resistance in EML4-ALK lung cancer cells2012

    • Author(s)
      Yamada T, et al.
    • Organizer
      5th Asia Pacific Lung Cancer Conference(oral presentation)
    • Place of Presentation
      ヒルトン福岡シーホーク(福岡県)
    • Year and Date
      2012-11-27
  • [Presentation] ALK肺がんのLigandによるALK阻害薬耐性機構とその克服2012

    • Author(s)
      山田忠明ら
    • Organizer
      第53回日本肺癌学会総会(ワークショップ)
    • Place of Presentation
      岡山コンベンションセンター(岡山県)
    • Year and Date
      2012-11-08
  • [Presentation] EGFR遺伝子変異陽性肺がんにおける新規足場蛋白Aki1の制御2012

    • Author(s)
      山田忠明ら
    • Organizer
      第71回日本癌学会総会(一般口演)
    • Place of Presentation
      ホテルロイトン札幌(北海道)
    • Year and Date
      2012-09-20
  • [Presentation] 非小細胞肺がんにおけるEGFR-TKI耐性2012

    • Author(s)
      山田忠明,矢野聖二
    • Organizer
      第10回日本臨床腫瘍学会学術総会(シンポジウム)
    • Place of Presentation
      大阪国際会議場(大阪府)
    • Year and Date
      2012-07-27
  • [Presentation] Hsp90 inhibition overcomes HGF-triggering resistance to EGFR-TKIs in EGFR mutant lung cancer by decreasing client protein expression and angiogenesis2012

    • Author(s)
      Yamada T, et al.
    • Organizer
      103thAmerican Association for Cancer Research Annual Meeting (Poster)
    • Place of Presentation
      McCormick Place(USA)
    • Year and Date
      2012-04-02
  • [Presentation] HGF/MET is a novel therapiutic target for EGFR-TKI resistant lung cancer2011

    • Author(s)
      Yamada T, Yano S
    • Organizer
      第70回日本癌学会総会(International Session)
    • Place of Presentation
      名古屋国際会議場(愛知県)
    • Year and Date
      2011-10-05
  • [Presentation] Treatment for EGFR mutant lung cancer2011

    • Author(s)
      山田忠明,矢野聖二
    • Organizer
      第9回日本臨床腫瘍学会学術総会(シンポジウム)
    • Place of Presentation
      パシフィコ横浜(神奈川県)
    • Year and Date
      2011-07-21
  • [Book] 実験医学2013

    • Author(s)
      山田忠明,矢野聖二
    • Total Pages
      33-38
    • Publisher
      羊土社
  • [Book] がん生物学 イラストレイテッド2011

    • Author(s)
      山田忠明,矢野聖二
    • Total Pages
      304-309
    • Publisher
      羊土社
  • [Remarks]

    • URL

      http://syuyounaika.w3.kanazawa-u.ac.jp/

URL: 

Published: 2014-09-25  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi